abinScience

abinScience is the research reagent brand of AtaGenix Laboratories (Wuhan, China). Our recombinant antibody portfolio is produced using animal-free expression systems including HEK293, CHO, and E. coli, ensuring batch-to-batch consistency without animal immunization. Product categories include: recombinant monoclonal antibodies, recombinant proteins, nanobodies (VHH), biosimilar reference antibodies, and conjugated antibodies for flow cytometry, IHC, and WB. Browse our catalog at www.abinscience.com.
The abinScience® brand was established in Strasbourg, France, drawing on AtaGenix’s 15 years of protein and antibody development expertise to deliver high-quality life science reagents. Since its founding in 2023, abinScience has been guided by its vision of “Empowering Bioscience Discovery,” committed to providing researchers worldwide with efficient and reliable experimental solutions to advance life science research.

Wuhan abinScience Biotechnology Co., Ltd., established in 2023, is the Asia-Pacific operations entity for the abinScience brand. It is responsible for reagent promotion, sales, and technical support across the Asia-Pacific market. The company leverages AtaGenix’s rigorous R&D framework and established international collaboration platform to deliver high-quality products and professional services to research institutions and pharmaceutical enterprises in the region.